Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening. 2015

Jing-Zhi Guan, and Wei-Ping Guan, and Toyoki Maeda, and Xie Guoqing, and Wan GuangZhi, and Naoki Makino
The 309th Hospital of Chinese People's Liberation Army, Beijing, China.

Lipid peroxidation due to oxidative stress (OS) may play an important role in the pathogenesis of chronic systemic inflammatory diseases such as multiple sclerosis (MS). Telomeres, repeated sequences that cap chromosome ends, undergo shortening with each cycle of cell division, resulting in cellular senescence. Research regarding telomere shortening has provided novel insight into the pathogenesis of various diseases. We hypothesized that OS damage leads to inflammatory reactions, which subsequently shortens the telomere length in MS. We enrolled 59 patients with MS, and age- and gender-matched 60 healthy controls. We divided MS subjects into three groups matched for age and gender according to the severity of disability: relatively benign course (BMS), secondary progressive MS, and primary progressive MS (PPMS). We analyzed the telomere length in peripheral blood mononuclear cells and the 8-iso-PGF2α concentration in urine, a reliable and stable marker of lipid peroxidation in vivo. The data showed significant higher levels of urinary 8-iso-PGF2α in MS subjects than in the controls. The lag-time, which represents the direct measurement of the resistance of low-density lipoprotein to oxidation, was shorter in the PPMS subjects than in the groups. Compared to that observed in the controls, the mean telomere length was significantly shorter in the PPMS group, whereas no significant telomere shortening was found between the controls and other subjects. Our data suggest that a decreased telomere length and enhanced lipid peroxidation reflects the severest stage of MS.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D015237 Dinoprost A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions. PGF2,PGF2alpha,Prostaglandin F2,Prostaglandin F2alpha,9alpha,11beta-PGF2,Enzaprost F,Estrofan,PGF2 alpha,Prostaglandin F2 alpha,9alpha,11beta PGF2,F2 alpha, Prostaglandin,F2alpha, Prostaglandin,alpha, PGF2
D059506 Telomere Shortening The loss of some TELOMERE sequence during DNA REPLICATION of the first several base pairs of a linear DNA molecule; or from DNA DAMAGE. Cells have various mechanisms to restore length (TELOMERE HOMEOSTASIS.) Telomere shortening is involved in the progression of CELL AGING. Shortening, Telomere,Shortenings, Telomere,Telomere Shortenings

Related Publications

Jing-Zhi Guan, and Wei-Ping Guan, and Toyoki Maeda, and Xie Guoqing, and Wan GuangZhi, and Naoki Makino
September 2022, International journal of molecular sciences,
Jing-Zhi Guan, and Wei-Ping Guan, and Toyoki Maeda, and Xie Guoqing, and Wan GuangZhi, and Naoki Makino
October 2016, Aging and disease,
Jing-Zhi Guan, and Wei-Ping Guan, and Toyoki Maeda, and Xie Guoqing, and Wan GuangZhi, and Naoki Makino
April 2011, The journal of nutrition, health & aging,
Jing-Zhi Guan, and Wei-Ping Guan, and Toyoki Maeda, and Xie Guoqing, and Wan GuangZhi, and Naoki Makino
June 2004, Annals of the New York Academy of Sciences,
Jing-Zhi Guan, and Wei-Ping Guan, and Toyoki Maeda, and Xie Guoqing, and Wan GuangZhi, and Naoki Makino
March 2011, Free radical biology & medicine,
Jing-Zhi Guan, and Wei-Ping Guan, and Toyoki Maeda, and Xie Guoqing, and Wan GuangZhi, and Naoki Makino
January 2015, Clinical biochemistry,
Jing-Zhi Guan, and Wei-Ping Guan, and Toyoki Maeda, and Xie Guoqing, and Wan GuangZhi, and Naoki Makino
October 2018, Mutation research. Genetic toxicology and environmental mutagenesis,
Jing-Zhi Guan, and Wei-Ping Guan, and Toyoki Maeda, and Xie Guoqing, and Wan GuangZhi, and Naoki Makino
May 2003, Free radical biology & medicine,
Jing-Zhi Guan, and Wei-Ping Guan, and Toyoki Maeda, and Xie Guoqing, and Wan GuangZhi, and Naoki Makino
January 2022, Journal of dietary supplements,
Jing-Zhi Guan, and Wei-Ping Guan, and Toyoki Maeda, and Xie Guoqing, and Wan GuangZhi, and Naoki Makino
April 2022, Multiple sclerosis and related disorders,
Copied contents to your clipboard!